NewslettersMammary Cell NewsNOS Inhibition Sensitizes Metaplastic Breast Cancer to PI3K Inhibition and Taxane Therapy via C-JUN RepressionBy Emily Salmini - January 2, 2025028Scientists reported that nitric oxide synthase (NOS) blockade potentiated response of human metaplastic breast cancer cell lines and tumors to phosphoinositide 3-kinase (PI3K) inhibitor alpelisib and taxane.[Nature Communications]Full Article